Skip to main content
. Author manuscript; available in PMC: 2022 Aug 19.
Published in final edited form as: Cell Rep. 2022 Jun 28;39(13):111018. doi: 10.1016/j.celrep.2022.111018

Figure 3. Flattening of glucocorticoid oscillations does not result in fat deposition in the liver, elevated circulating triglycerides in blood serum, or defects in thermogenesis.

Figure 3.

(A) Representative image of H&E staining of livers 21 days after placebo or cort-pellet implantation (n = 4). Weight of livers at different time points after pellet implantation. n = 4–5, means ± SDs. See also Table S1 and Figure S3.

(B) Time courses of changes in FFAs, glycerol, and triglycerides measured in blood serum after 14 days in fasted mice. n = 4–5, means ± SEMs, unpaired t test; *p < 0.05; ns, not significant.

(C and D) Same as in (A) and (B), but instead for daily placebo or cort-injected mice, n = 3–4.

(E) Flattening of daily GC oscillations results in downregulation of genes involved in thermogenesis. mRNA expression for UCP-1 measured by qPCR in BAT, normalized to the expression of Tbp, and presented as means ± SEMs (n = 3–4). Unpaired t test; *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. Control group are mice at start of experiment (day 0).

(F) Western blot analysis of UCP-1 in BAT lysates (see Figure S3M for quantification).

(G) Acute cold exposure experiment of placebo and cort-pellet-implanted mice 21 days after pellet implantation. Means ± SEMs; n = 8.